Coronavirus treatment: Experimental drug in trial phase
An experimental drug that could prevent Covid-19 patients from becoming seriously ill is being trialled in England.
The BBC’s Fergus Walsh spoke to two volunteers who are taking part in the trial at the Royal Liverpool University Hospital.
The BBC’s Fergus Walsh spoke to two volunteers who are taking part in the trial at the Royal Liverpool University Hospital.
Other posts
LIVERPOOL, England, 20 April 2021 — The University of Liverpool, Liverpool School of Tropical Medicine, and the NIHR Southampton Clinical Trials Unit at the University…
People across the south are being asked to play their part in helping vital research into new COVID-19 treatments. A ground-breaking clinical trial platform being…
The AGILE drug testing platform has received a multi-million pound award from the UK government’s Department of Health and Social Care to fast track the…
GlaxoSmithKline and Vir Biotechnology have joined forces with researchers from the Universities of Liverpool and Southampton, who are leading an accelerated early phase trials platform…
An experimental drug that could prevent Covid-19 patients from becoming seriously ill is being trialled in England. The BBC’s Fergus Walsh spoke to two volunteers…
Take a look at this case study from @Medidata who are supporting @SouthamptonCTU with the AGILE clinical trial platform #COVID19 #clinicaltrials